Back to Dashboard
20

DHCNI

🏠 Real Estate

Diversified Healthcare Trust -

Conservative #1275Aggressive #1370Low RiskML↑ 23pt
$16.76-3.68%
Day High$17.70
Day Low$16.46
Volume0.1M
Mkt Cap$837M
52W Low $1352W High $18
Market Cap
$892M
P/E Ratio
N/A
Rev Growth
6.0%
Sector avg: 15420.2%
Earnings Growth
-26.1%
Profit Margin
-22.9%
Sector avg: 6.3%
Debt/Equity
1.61

Why This Score

DHCNI scores 20.5 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.

Strengths
  • Positive but moderate momentum (27%) — steady appreciation without overheating.
Risk Factors
  • Liquidity concern: Limited trading volume or float results in a 25-point penalty for execution risk.
  • Elevated leverage (D/E 1.61) increases financial risk in a rising-rate environment.

Net penalties of -26.9 points significantly impact the ranking. Without these adjustments, DHCNI would rank considerably higher.

Score Breakdown

Overall Score20.5
Fundamental Score45.9
ML Score32.0

Score by Horizon

3 Month
50.8
6 Month
56.8
Primary
1 Year
59.8

Quality Assessment

F
Quality Grade
Low quality — significant fundamental weaknesses

Position Sizing

Suggested Allocation
5%
Confidence
medium

Score Composition Waterfall

How each component affects the final score
Backtested Scoring Levers (IC-calibrated from 30y ElasticNet)
Weinstein (12.1%)
0
Declining
Sentiment (2.5%)
49
Neutral
Analyst (6.4%)
50
Neutral
Tradability (post-hoc)
0
Grade Fvery low volume, very low dollar volume
Base
18.1
SHAP
+3.2
Factors
+0.2
Conviction
-1.0
Final
20.5
Positive adjustment
Negative adjustment
Base blend
Final score

Factor Breakdown

40AVG
Value50
Quality11
Growth26
Stability72
Investment42

Signal SegmentsComputed from ML features

Fundamental (Valuation, Quality, Growth)40.0
Technical (Momentum, Weinstein, Volatility)82.0
External (Sentiment, Analyst, Macro)62.0
Scores below 50 indicate weakness in that segment relative to the universe.

Data Quality

Score
Features
Confidence
Feature Coverage89%

Growth Estimates

Short-term
-3.3% to +0.9%
Medium-term
-4.7% to +1.6%
Long-term
-6.1% to +2.2%

ML Model Core Features100 trained inputs → ML Score: 32

These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.

Analyst Intelligence
Consensus Score50.0/100
Target Upside+0.0%
Coverage0 analysts
Market Sentiment
Sentiment Score48.8/100
News Volume1 articles
Technical Stage
Weinstein Stage4 — Declining
12M Momentum+0.3%
6M Momentum+0.1%
Volatility+0.1%
Momentum & Technical
Momentum Acceleration+16.3%
Momentum ConsistencyModerate (0.39)
Relative Strength vs Sector+23.4%
Trend Strength (ADX Proxy)Strong (3.1)
Momentum Quality+0.255
Momentum BreadthBroad ✓
Macro Regime
Bull RegimeYes
High Vol RegimeNo
S&P 500 Return+25.0%
Yield Curve-0.1bp

Sector-Relative AnalysisIn-model features

Value Trap Signal
7%
Low risk
Sector RevGr Rank
P50
Revenue growth vs Real Estate peers
Sector PE Rank
P50
Valuation vs Real Estate peers
Sector FCF Rank
P27
Free cash flow vs Real Estate peers
Growth Deviation
-0.0σ
Z-score vs sector median
Stagnation Flag
NO
Not flagged

Analysis Signals

Scoring Factors
Fundamental score of 46 relative to sector peers46/100
Machine learning ensemble ranks this stock at the 32th percentileP32
Blended score: 80% fundamental (46) + 20% ML (32) = 43.143.1
Risk assessment: low. Low vol 0.1%; Drawdown 5% → 0.0ptLow
Earnings quality grade F: quality flags triggered — see details below. Score adjusted by 0 pointsGrade F
SHAP feature alignment: +3.2pt (features align with model priorities)SHAP
Conviction adj: -1.0pt (conviction=N/A)Conviction
Risk Factors
Liquidity penalty: -25.0pt (grade F)Liquidity

Sector Peer Comparison(Real Estate — Rank #25 of 27 stocks)

StockScoreP/ERev GrowthMarginMkt Cap
DHCNI20.5N/A6.0%-22.9%$892M
AGNC80.67.5-60.8%87.0%$12.4B
SBAC76.825.3-1.2%28.0%$21.0B
GLPI76.016.66.3%51.2%$13.9B
REG74.227.16.9%34.0%$14.4B
LAMR72.131.04.6%16.4%$13.9B
HST71.718.87.0%12.3%$13.7B
SBRA69.731.510.2%20.1%$5.3B
ADAM66.04.912.0%19.9%$754M
PECO65.644.110.7%15.3%$5.0B
LAND64.340.1-5.7%14.5%$457M
EQIX62.569.45.4%14.6%$93.6B
DRH61.131.95.1%5.7%$2.1B
GOOD54.130.78.0%12.0%$613M
RMR53.911.8-22.0%3.5%$525M
FISV47.89.47.1%15.3%$33.3B
Sector Average50.932.315420.2%6.3%—

Market Sentimentvia FMP

No analyst sentiment data available for DHCNI.

Company Overviewvia FMP

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. The SHOP segment manages senior living communities that offers short term and long term residential care, and other services for residents where it pay fees to the operator to manage the communities for its account. The company was founded on December 16, 1998 and is headquartered in Newton, MA.

CEO
None
Beta
1.14
Industry
REIT - Industrial
FMP-Identified Peers

Technical Picturecomputed from daily prices

RSI (14)
42.8
Neutral
Trend
Bullish
10-day vs 50-day MA
From 52W High
-8.4%
High: $18.29
From 52W Low
+31%
Low: $12.79
Moving Averages
10-Day
$17.50
Below
20-Day
$17.40
Below
50-Day
$17.10
Below
200-Day
$16.80
Below
60-Day Support
$15.85
60-Day Resistance
$17.99
Weinstein Stage Analysisbased on 200-day SMA framework
Stage 4 — DecliningScore: 28/100

Stock is in a downtrend below the 200-day moving average. Price is below both the 50-day and 200-day SMAs, indicating sustained selling pressure.

Unfavorable technical position; wait for Stage 1 basing
Transition signal: 3→4
Price vs 200 SMA
-0.2%
200 SMA Slope (60d)
+5.38%
Rising
Volume Ratio
0.83x
10d avg vs 50d avg
Days in Stage
1
Confidence: 50%

Entry & Exit Zones

Avoid
No Entry
—
No entry — active downtrend
Exit Target
—
Exit position if held
Stop Level
—
No stop — exit recommended

Stage 4 downtrend — price is below both SMA50 and SMA200 with a declining 200-day average. Capital preservation takes priority. Do not buy into a downtrend.

Technical zones only — derived from moving averages and price structure. Not financial advice. Past technical patterns do not guarantee future performance.

Financial Statementslast 4 quarters via FMP

MetricQ4 2025Q3 2025Q2 2025Q1 2025
Revenue$380M$389M$383M$387M
Gross Profit$-51M$63M$70M$73M
Operating Income$-11M$-15M$-7M$64M
Net Income$-21M$-164M$-92M$-9M
EPS (Diluted)$-0.09$-0.68$-0.38$-0.04
Gross Margin-13.6%16.3%18.3%18.7%
Operating Margin-2.9%-3.8%-1.9%16.4%
Net Margin-5.6%-42.2%-23.9%-2.3%

Why This Stock

Real Estate

Tradability FilterGrade F — 0/100Score impact: -27.2pt

Low Tradability Warning

This stock has limited trading volume and/or float. Institutional investors may face difficulty entering or exiting positions without significant price impact. A post-hoc penalty has been applied to the composite score (this is not a backtested model factor — it is a practical tradability overlay).

Volume
0
33K avg/day
Dollar Vol
0
$572K/day
Float
0
0K shares
Mkt Cap
0
$892M
Range
0
43% spread
Composite Liquidity Score0/100
FDCBA
very low volumevery low dollar volume

Multi-Year Range Analysis

Sideways: 9/100
YearLowHighRangeStatus
2021$20.28$24.8620.3%Narrow
2022$9.51$22.5081.2%Wide
2023$10.21$16.1044.8%Wide
2024$12.37$17.4634.1%Moderate
2025$12.79$18.2935.4%Wide
3-Year Range
56.7%
Narrow Years
1 / 5
Sideways Penalty
None
Free Float
0.0%
Outstanding Shares
0M
Bid-Ask Spread
43.0%
Institutional Tradable
No

Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.